Navigation Links
Adventrx To Develop ANX-188 For Complications Of Arterial Disease
Date:2/28/2013

al hold"; the risk of suspension or termination of a clinical study, including due to lack of adequate funding or patient safety concerns; the potential for institutional review boards or the FDA or other regulatory agencies to require additional nonclinical or clinical studies prior to initiation of planned phase 2 clinical studies of ANX-188 in any particular indication in which ADVENTRX determines to develop ANX-188, including ALI, which likely would increase the total time and cost of development in the indication; the risk that clinical studies of ANX-188 are not successfully executed and/or do not successfully demonstrate its safety or efficacy; the risk that, even if clinical studies are successful, the FDA determines they are not sufficient to support a new drug application; the risk that even if clinical studies of ANX-188 in one indication are successful, clinical studies in another indication may not be successful; ADVENTRX's reliance on contract research organizations (CROs), contract manufacturing organizations (CMOs), and other third parties to assist in the conduct of important aspects of development of ANX-188, including clinical studies, and regulatory activities for ANX-188 and that such third parties may fail to perform as expected; ADVENTRX's ability to obtain additional funding on a timely basis or on acceptable terms, or at all; the potential for ADVENTRX to delay, reduce or discontinue current and/or planned development activities, including clinical studies, partner ANX-188 at inopportune times or pursue less expensive but higher-risk development paths if it is unable to raise sufficient additional capital as needed; the risk that acceptable partnering opportunities for ANX-188 may not be available in particular jurisdictions or indications and, consequently, ADVENTRX may not be able to pursue development of ANX-188 in certain jurisdictions and indications; the risk that the FDA does not grant marketing approval of ANX-188, on a timely basis,
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications
2. ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4
3. ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12
4. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
5. ADVENTRX Reports Third Quarter 2012 Financial Results
6. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
7. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
8. ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10
9. ADVENTRX Announces Appointment Of Chief Medical Officer
10. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
11. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... CHAPEL HILL, N.C. , Oct. 17, 2014 ... healthcare landscape, the Medical Affairs function has come ... metrics, allocating resources efficiently and managing globalization.  ... at Best Practices, LLC is dedicated to providing ... issues. The Medical Affairs Consortium is a service ...
(Date:10/17/2014)... AUSTIN, Texas , Oct. 17, 2014  Hanger, ... it plans to report its results of operations for ... 6, 2014 after the market closes.  A conference call ... 9:00 a.m., ET, on Friday, November 7, 2014. Those ... be available until Friday, November 14, 2014 by dialing ...
(Date:10/17/2014)... , Oct. 17, 2014 UBM Medica US announces ... leading online community and information resource for neurologists and other ... and Alzheimer disease , with discussions of the latest ... 1 million Americans have Parkinson disease , more than the ... Lou Gehrig disease. Diagnosis can be difficult because ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... Program (CCRP) invites golfers to participate in its second annual,"Drive ... Valley Country Club,14601 Country Club Drive, Aurora. The private club ... home to major events such as the,Colorado Women,s Open. The ... been inducted into the Colorado Hall of Fame., By ...
... Vision Improved from Detecting Hand Movements to Reading,Lines ... In a clinical trial,at The Children,s Hospital of ... gene therapy to safely restore vision in three,young ... Although the,patients have not achieved normal eyesight, the ...
Cached Medicine Technology:Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer 2Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 2Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 4Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 5Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 6Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 7Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 8
(Date:10/22/2014)... Best Cheap Hosting USA is among ... site has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) ... from around the world. , “iPower is one of ... is providing various kinds of useful products for new ... offering excellent customer service and a number of features ...
(Date:10/22/2014)... 2014 Lintelus, Inc., an event software ... of Sales, will be speaking on the subject of ... on October 28, at the Holiday Inn in New ... as well as a Tech Demo at 12:45pm, to ... a more engaging event experience. , The Annual Meetings ...
(Date:10/22/2014)... Salamon HealthDay Reporter , TUESDAY, ... vitro fertilization (IVF) are only about half as likely as ... technique, new research indicates, and the racial disparity persists even ... 31 percent of white patients became pregnant after IVF, compared ... than 4,000 IVF cycles over two years to tease out ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 With a ... Gov. Charlie Crist made a brief fundraising stop at ... on Thursday. , Fresh from a debate last night ... take the stage for the first seven minutes because ... former governor described the incident in one word: "weird." ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3
... Washington, The out of the ordinary sex life of the ... lead to infertility in humans. ,Mole-rats are ... are ruled over by a queen. ,In a ... learn more about how stress affects fertility in both men ...
... from Napoleon Bonaparte to his future wife Josephine sold for ... auction of original handwritten letters by historical figures -- ... letter from the future French leader fetched 276,000 pounds (409,000 ... had only been expected to fetch 50,000 pounds. ...
... to new figures presented at the European Society of ... Germanys embryo protection law has had the unintended consequence ... treatment. , ,The German embryo protection law, passed ... can be created per cycle of IVF and all ...
... from OSI Pharmaceuticals, Inc found that the appearance of a ... strongly associated with longer survival. ,This is not ... survival advantage with EGFR inhibitors - a class of drugs ... overproduction of the epidermal growth factor receptor - but it ...
... France are being analysed to see if they carried the H5N1 ... the agriculture ministry said Tuesday. ,'First analyses have established ... see ... if this is an infection with the H5N1 strain,' ... in the meantime measures have been taken to seal off the ...
... never get pregnant, for she thinks that the unhealthy lifestyle ... Girls has done permanent damage to her health. ,The singer ... she did a lot of harm to her image as she ... ,I was underweight and my image was unhealthy. There ...
Cached Medicine News:Health News:Strange Sex Life of Mole-rats may Provide Clues About Human Infertility 2Health News:Napoleon Love Letter Seduces Bidders at Manuscript Auction 2Health News:Embryo Protection Law in Germany 2Health News:Embryo Protection Law in Germany 3Health News:Embryo Protection Law in Germany 4Health News:Skin Rashes Signifies Longer Survival in Cancer Patients 2Health News:Skin Rashes Signifies Longer Survival in Cancer Patients 3Health News:Sporty Spice Fears That She Might Never Get Pregnant 2
... positive and negative whole blood control to ... in solubility tests and hemoglobin electrophoresis. Sickle-Chex ... other manufacturers' solubility kits. Sickle-Chex is packaged ... The vial dispenses an accurate sample volume. ...
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... blood assayed hematology control, offers complete assay ... available with the Coulter GENS, STKS, MAXM ... open-vial stability, 105-day closed-vial stability and is ... The 4.0ml pierceable cap vial is compatible ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Medicine Products: